NCT03422367

Brief Summary

The investigators are running an intervention study for young children with Tuberous Sclerosis Complex (TSC). The study will include free play-based behavioral intervention administered remotely that may improve social and communication skills in children with TSC. Eligible families will have a child in the age range of 12-36 months, with a diagnosis of TSC. Children with TSC below 12 months may be eligible for an early markers study prior to enrollment in the intervention trial. The intervention will focus on teaching caregivers skills to improve the social and communication outcomes of their children. The content of the intervention will be individually tailored to the child's developmental level. The intervention involves 4 on-site assessment visits, and 12 weekly intervention sessions, administered in-person and remotely. The intervention focuses on improving social-communication and play skills.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 24, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 30, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 5, 2018

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2022

Completed
Last Updated

November 6, 2020

Status Verified

November 1, 2020

Enrollment Period

4.6 years

First QC Date

January 30, 2018

Last Update Submit

November 5, 2020

Conditions

Keywords

autismepilepsyasdTSCUCLALos AngelesJASPERinterventionBostonBCHMGH

Outcome Measures

Primary Outcomes (10)

  • ESCS (Early Social Communication Scales) Assessment.

    Change from baseline in the amount of time spent in a Joint Attention (the coordination of attention between objects and people for the purpose of sharing) state at 3 months; ESCS is an experimental measure reported as frequency for requesting and joint attention in 15-minute intervals

    3 months

  • ESCS (Early Social Communication Scales) Assessment.

    Change from baseline in the amount of time spent in a Joint Attention (the coordination of attention between objects and people for the purpose of sharing) state at 6 months; ESCS is an experimental measure reported as frequency for requesting and joint attention in 15-minute intervals

    6 months

  • Parent Caregiver Interaction assesses the amount of time the parent and child spend in engaged in the same play routine.

    change from baseline in Joint Engagement (shared engagement in a play routine) at 3 months into study participation, according to the parent caregiver interaction assessment.

    3 months

  • Parent Caregiver Interaction assesses the amount of time the parent and child spend in engaged in the same play routine.

    change from baseline in Joint Engagement (shared engagement in a play routine) at 6 months into study participation, according to the parent caregiver interaction assessment.

    6 months

  • Structured Play Assessment (SPA)

    Change from baseline in Symbolic Play (types of play and level of play) at 3 months; this is an experimental measure reported as types of behaviors reflecting flexibility and diversity of the child's play level, based on distinct sets of toys that target specific developmental markers of play.

    3 months

  • SPA

    Change from baseline in Symbolic Play (types of play and level of play) at 6 months; this is an experimental measure reported as types of behaviors reflecting flexibility and diversity of the child's play level, based on distinct sets of toys that target specific developmental markers of play.

    6 months

  • Mullen Scales of Early Learning (MSEL)

    Measures cognitive ability and language development (baseline to 3 months). The test has five scales: gross motor, visual reception, fine motor, receptive language, and expressive language. The test identifies the subject's strengths and weaknesses and assesses early intellectual development.

    3 months

  • Mullen

    Measures cognitive ability and language development (baseline to 6 months). The test has five scales: gross motor, visual reception, fine motor, receptive language, and expressive language. The test identifies the subject's strengths and weaknesses and assesses early intellectual development.

    6 months

  • Social communication

    Change from baseline at 3 months in the amount of Parent use of social communication support strategies Parent use of social communication support strategies as taught by JASPER will be measured by a parent-child interaction assessment.

    3 months

  • Social communication

    Change from baseline at 3 months in the amount of Parent use of social communication support strategies Parent use of social communication support strategies as taught by JASPER will be measured by a parent-child interaction assessment.

    6 months

Study Arms (3)

Treatment Group

EXPERIMENTAL

The Treatment Group begins the JASPER intervention immediately upon enrollment in the study.

Behavioral: JASPER

Delayed Treatment Group

ACTIVE COMPARATOR

The Delayed treatment group receives the same JASPER intervention as the Treatment Group, but after 6 months of receiving services in the community as usual.

Behavioral: JASPER

Control

NO INTERVENTION

Participants who are unable to complete JASPER due to age or time/distance commitment can enroll for single-time point participation

Interventions

JASPERBEHAVIORAL

JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation) is a treatment approach based on a combination of developmental and behavioral principles developed by Dr. Connie Kasari and Dr. Amanda Gulsrud at UCLA. It targets the foundations of social communication (joint attention, imitation, play) and uses naturalistic strategies to increase the rate and complexity of social communication.

Also known as: Joint Attention; Symbolic Play and Engagement Regulation
Delayed Treatment GroupTreatment Group

Eligibility Criteria

Age6 Months - 40 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • A confirmed diagnosis of Tuberous Sclerosis Complex

You may not qualify if:

  • A mental age less than 6 months. A plan for epilepsy surgery during the study participation period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of California Los Angeles

Los Angeles, California, 90065, United States

RECRUITING

Boston Children's Hospital

Boston, Massachusetts, 02215, United States

RECRUITING

Related Publications (1)

  • Hyde C, Pizzano M, McDonald NM, Nelson CA 3rd, Kasari C, Thiele EA, Jeste SS. A telehealth approach to improving clinical trial access for infants with tuberous sclerosis complex. J Neurodev Disord. 2020 Jan 22;12(1):3. doi: 10.1186/s11689-019-9302-0.

Related Links

MeSH Terms

Conditions

Tuberous SclerosisAutistic DisorderEpilepsyChild Development Disorders, Pervasive

Interventions

Activator Appliances

Condition Hierarchy (Ancestors)

HamartomaNeoplasmsNeoplasms, Multiple PrimaryNeoplastic Syndromes, HereditaryMalformations of Cortical Development, Group IMalformations of Cortical DevelopmentNervous System MalformationsNervous System DiseasesNeurocutaneous SyndromesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, InbornAutism Spectrum DisorderNeurodevelopmental DisordersMental DisordersBrain DiseasesCentral Nervous System Diseases

Intervention Hierarchy (Ancestors)

Orthodontic Appliances, FunctionalOrthodontic AppliancesOrthodonticsDentistryOrthodontic Appliances, Removable

Study Officials

  • Shafali Jeste

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Developmental Neurophysiology Lab

Study Record Dates

First Submitted

January 30, 2018

First Posted

February 5, 2018

Study Start

October 24, 2017

Primary Completion

June 15, 2022

Study Completion

June 15, 2022

Last Updated

November 6, 2020

Record last verified: 2020-11

Locations